SCHEMBL8103882

SCHEMBL8103882

CCCN(CCC)C1Cc2cc3c(cc2C1)CN(S(=O)(=O)c1cc(Cl)c(Cl)s1)C3

nearest known ligand 0.42

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ FYN P06241 2/20 0.42
▸ ALDH1A1 P00352 2/20 0.40
▸ CYP2D6 P10635 2/20 0.40
▸ CYP2C9 P11712 1/20 0.40
▸ ALOX15 P16050 1/20 0.40
▸ MAPK1 P28482 1/20 0.40
▸ EPHX2 P34913 1/20 0.40
▸ DRD3 P35462 7/20 0.39
▸ DRD2 P14416 6/20 0.39
▸ DRD4 P21917 4/20 0.39
▸ MEN1 O00255 2/20 0.36
▸ KMT2A Q03164 2/20 0.36
▸ HTR1A P08908 1/20 0.36
▸ ADRB2 P07550 1/20 0.36
▸ CASP1 P29466 1/20 0.36
▸ LMNA P02545 2/20 0.36
▸ MAPT P10636 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8108257 0.79 DRD3 (0.48) FYNALDH1A1CYP2D6CYP2C9ALOX15
SCHEMBL7450611 0.78 FYN (0.45) FYNALDH1A1CYP2D6CYP2C9ALOX15
SCHEMBL7457739 0.76 ALDH1A1 (0.46) FYNALDH1A1CYP2D6CYP2C9ALOX15
SCHEMBL6431031 0.70 MEN1 (0.54) DRD3DRD2DRD4MEN1KMT2A
SCHEMBL7449830 0.69 MCOLN3 (0.44) FYNDRD3HTR1A
SCHEMBL7455176 0.67 ALDH1A1 (0.50) ALDH1A1MAPK1MEN1KMT2ALMNA
SCHEMBL7452274 0.64 FYN (0.58) FYNALDH1A1CYP2D6CYP2C9ALOX15
SCHEMBL7403093 0.63 DRD3 (0.59) FYNALDH1A1CYP2D6CYP2C9ALOX15
SCHEMBL8693035 0.63 FYN (0.70) FYNALDH1A1CYP2D6CYP2C9ALOX15
SCHEMBL7404669 0.62 FYN (0.51) FYNALDH1A1CYP2D6CYP2C9ALOX15

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6084130-A FOR TREATMENT OF CENTRAL NERVOUS SYSTEM DISORDERS PHARMACIA & UPJOHN COMPANY (US) 2000-07-04 — — US disclosed
Send feedback